Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares | The Motley Fool

This biotech innovator in genetic disease therapies reported a notable insider sale amid a year of dramatic share price gains.

By Rogue Orion · March 28, 2026 · 1 min read

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares | The Motley Fool

Source: The Motley Fool

This biotech innovator in genetic disease therapies reported a notable insider sale amid a year of dramatic share price gains.

Related Posts

Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know | The Motley Fool

by Rogue Orion · Mar 28, 2026

#lgnd #04a6ab6d-771b-483e-b596-bf6ed6698e25 #coveragefilings
Alphatec CFO Sells $986K in Stock With Shares Up 9% This Past Year. Here's What Investors Should Know | The Motley Fool

by Rogue Orion · Mar 28, 2026

#atec #065b4215-d950-442d-b385-45a58c6eb64f #coveragefilings
Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More | The Motley Fool

by Rogue Orion · Mar 28, 2026

#crnx #33a16fbc-b626-487d-9a4d-68455c670b92 #coveragefilings
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know

by Rogue Orion · Mar 28, 2026

#lmat #c8024e87-1453-46ee-8f27-9b78f722c3c0 #coveragefilings
This F&G Insider Spent $100,000 Buying Shares Despite a Steep Stock Plunge. Is It Time for a Turnaround?

by Rogue Orion · Mar 28, 2026

#fg #70bc1503-c4c7-499b-bb09-2d6ab47cbc73 #coveragefilings

Trending on ShareHub

Latest on ShareHub

Browse Topics

#artificial intelligence (5111)#deep learning (3221)#pro graphics (2571)#ai (1800)#news (1710)#generative ai (1655)#3d (1638)#gaming (1631)#geforce now (1192)#cloud gaming (1161)

Around the Network